Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Rymko · SciRah

Researcher profile · Semantic Scholar

M. Rymko

Share profile

M. Rymko — researcher profile on SciRah

h-index: 10
Works: 37
Citations: 302

Most-cited papers

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
M. Pertesi, M. Vallée, Xiaomu Wei, M. Revuelta +88 more
2019Leukemia41 citations Open access
Semantic Scholar
Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study
A. Jurczyszyn, H. Nahi, I. Avivi, A. Gozzetti +20 more
2016British Journal of Haematology41 citations Open access
Semantic Scholar
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study
E. Kalicińska, M. Biernat, J. Rybka, Aleksander Zińczuk +10 more
2021Journal of Clinical Medicine38 citations Open access
Semantic Scholar
Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
J. Zaleska, P. Kwaśnik, M. Paziewska, J. Purkot +30 more
2022International Journal of Cancer24 citations Open access
Semantic Scholar
Genetically determined telomere length and multiple myeloma risk and outcome
M. Giaccherini, A. Macauda, E. Orciuolo, M. Rymko +45 more
2021Blood Cancer Journal17 citations Open access
Semantic Scholar
Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study
E. Kalicińska, D. Szymczak, Iga Andrasiak, A. Bogucka-Fedorczuk +9 more
2020Translational Oncology17 citations Open access
Semantic Scholar
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients
A. Macauda, E. Castelli, G. Buda, M. Pelosini +27 more
2018British Journal of Haematology15 citations Open access
Semantic Scholar
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study
D. Campa, A. Martino, A. Macauda, M. Dudzinski +43 more
2019Leukemia and Lymphoma14 citations Open access
Semantic Scholar
Identification of miRSNPs associated with the risk of multiple myeloma
A. Macauda, Diego Calvetti, G. Maccari, K. Hemminki +52 more
2017International Journal of Cancer12 citations Open access
Semantic Scholar
A polygenic risk score for multiple myeloma risk prediction
F. Canzian, Chiara Piredda, A. Macauda, D. Zawirska +36 more
2021European Journal of Human Genetics10 citations Open access
Semantic Scholar
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
A. Macauda, Chiara Piredda, A. Clay-Gilmour, J. Sainz +50 more
2021International Journal of Cancer10 citations Open access
Semantic Scholar
Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia
Anna Marta Madejczyk, F. Canzian, J. Góra-Tybor, D. Campa +9 more
2022Frontiers in Oncology9 citations Open access
Semantic Scholar
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
A. Macauda, Klara Briem, A. Clay-Gilmour, W. Cozen +62 more
2023Leukemia7 citations Open access
Semantic Scholar
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium
E. Iskierka-Jażdżewska, F. Canzian, A. Stępień, A. Martino +26 more
2019Leukemia and Lymphoma7 citations Open access
Semantic Scholar
Real‑life experience with bortezomib‑based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter study.
I. Hus, A. Walter-Croneck, A. Masternak, A. Jurczyszyn +8 more
2017Polish Archives of Internal Medicine7 citations Open access
Semantic Scholar
Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium
E. Iskierka-Jażdżewska, A. Stępień, F. Canzian, A. Martino +25 more
20146 citations Open access
Semantic Scholar
Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group.
L. Usnarska-Zubkiewicz, Jakub Dębski, A. Butrym, W. Legieć +29 more
2016Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis5 citations Open access
Semantic Scholar
Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.
A. Walter-Croneck, N. Grząśko, M. Soroka-Wojtaszko, A. Jurczyszyn +32 more
2014Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis5 citations Open access
Semantic Scholar
Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival
O. Melaiu, A. Macauda, J. Sainz, Diego Calvetti +50 more
2020International Journal of Cancer4 citations Open access
Semantic Scholar
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function.
L. Pour, S. Delimpasi, W. Legieć, J. Minařík +9 more
2026Clinical Lymphoma, Myeloma & Leukemia3 citations Open access
Semantic Scholar
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide and dexamethasone (VRd) in patients with newly diagnosed multiple myeloma (NDMM) – interim results from the randomized Phase III COBRA trial.
D. Dytfeld, T. Kubicki, A. Tyczyńska, M. Rymko +27 more
2025Blood3 citations
Semantic Scholar
Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy
Agnieszka Bielewicz-Zielińska, J. Brzezicki, M. Rymko, S. Jeka
2015Rheumatology3 citations Open access
Semantic Scholar
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Myeloma Patients?
A. Macauda, A. Clay-Gilmour, T. Hielscher, M. Hildebrandt +52 more
2022Cancer Epidemiology, Biomarkers and Prevention2 citations Open access
Semantic Scholar
Dynamics of Stomach Growth in the Human Fetal Period: a Postmortem Study
B. Gworys, S. Jeka, Radoslaw Brukiewa, M. Rymko
20122 citations Open access
Semantic Scholar
MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: First Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)
Krzysztof Jamroziak, E. Iskierka-Jażdżewska, Sebastian Giebel, Kamil Wiśniewski +20 more
2024Blood1 citations
Semantic Scholar
Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group
L. Usnarska-Zubkiewicz, Jakub Dębski, A. Butrym, W. Legieć +12 more
20131 citations
Semantic Scholar
Leveraging Ensemble Machine Learning Models for the Detection of Primary Myelofibrosis in Electronic Health Records
Arkadiusz Sycz, Michal J. Dabrowski, Kinga Marciniak, Aleksandra Jurczuk +20 more
2026Cancers0 citations Open access
Semantic Scholar
An open-label, Phase I/II clinical trial of romaciclib (RVU120) as monotherapy and in combination with ruxolitinib in patients with intermediate or high-risk, primary or secondary myelofibrosis (POTAMI-61)
Tomasz Sacha, M. Rymko, Katarzyna Dulik, S. Grosicki +13 more
2025Blood0 citations
Semantic Scholar
Minimal residual disease-guided venetoclax plus rituximab for patients with previously untreated chronic lymphocytic leukemia (VERITA PALG-CLL5): primary endpoint analysis of the prospective, multicenter, Phase 2 trial
Krzysztof Jamroziak, E. Iskierka-Jażdżewska, Tadeusz Robak, K. Zielonka +23 more
2025Blood0 citations
Semantic Scholar
Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach.
Patryk Sobieralski, M. Bieniaszewska, Ł. Bołkun, Tomasz Sacha +9 more
2024Advances in Clinical and Experimental Medicine0 citations Open access
Semantic Scholar
SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA
D. Dytfeld, J. Radocha, R. Hájek, Güldane Cengiz Seval +30 more
2023Acta Haematologica Polonica0 citations Open access
Semantic Scholar
P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
J. Zaleska, P. Kwaśnik, M. Paziewska, J. Purkot +33 more
2022HemaSphere0 citations Open access
Semantic Scholar
hematologicznych Retrospective analysis of nilotinib and dasatinib ef ﬁ cacy in second line treatment of chronic myeloid leukemia in Polish hematological centers Polonica
K. Jamroziak, T. Sacha, D. Link-Lenczowska, I. Florek +8 more
20160 citations
Semantic Scholar
Atypical course of Henoch-Schonlein purpura in an adult patient
Agnieszka Bielewicz-Zielińska, Bożena Górnikiewicz-Brzezicka, J. Brzezicki, M. Rymko +1 more
2015Rheumatology0 citations Open access
Semantic Scholar
Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)
A. Stępień, A. Martino, F. Canzian, D. Campa +14 more
20140 citations
Semantic Scholar
Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group
L. Usnarska-Zubkiewicz, Jakub Dębski, A. Butrym, W. Legieć +6 more
20110 citations
Semantic Scholar
Principles of a fluorescence phenomenon and its application in medicine
S. Jeka, J. Fisz, P. Żuchowski, M. Rymko
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Jurczyszyn×17
Invite
A. Jurczyszyn — researcher profile on SciRah
K. Jamroziak×16
Invite
K. Jamroziak — researcher profile on SciRah
A. Butrym×15
Invite
A. Butrym — researcher profile on SciRah
A. Druzd-Sitek×15
Invite
A. Druzd-Sitek — researcher profile on SciRah

×14

Invite

M. Dudzinski — researcher profile on SciRah

Invite

F. Canzian — researcher profile on SciRah

Invite

E. Subocz — researcher profile on SciRah

E. Iskierka-Jażdżewska×13

Invite

E. Iskierka-Jażdżewska — researcher profile on SciRah

Invite

D. Campa — researcher profile on SciRah

Invite

J. Zaucha — researcher profile on SciRah

Marzena Wątek×12

Invite

Marzena Wątek — researcher profile on SciRah

M. Kruszewski×11

Invite

M. Kruszewski — researcher profile on SciRah